Template:Labetalol: Difference between revisions

Latest revision as of 20:33, 5 February 2014

Labetalol
LABETALOL tablet^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
LABETALOL injection^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Labetalol
ClinicalTrials.gov

@@ Line 27: / Line 27: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[labetalol tablet nonclinical toxicology|Nonclinical Toxicology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[labetalol tablet clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[labetalol tablet how supplied storage and handling|How Supplied/Storage and Handling]]
@@ Line 61: / Line 59: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[labetalol injection nonclinical toxicology|Nonclinical Toxicology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[labetalol injection clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[labetalol injection how supplied storage and handling|How Supplied/Storage and Handling]]